Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
4 December 2025
Patent litigation in generic drug markets is delaying affordable medicines, costing billions annually. Learn how the Hatch-Waxman Act, Orange Book listings, and pay-for-delay settlements are shaping access to generics.